• Home
  • Venus Pharma GmbH

Venus Pharma GmbH

  • Company/product certifications
About Venus Pharma GmbH

Venus Remedies Limited/Venus Pharma GmbH, globally recognized for their unwavering commitment to quality and innovation, proudly holds EU-GMP certification in injectable manufacturing, a testament to their world-class manufacturing standards. With a vast global footprint spanning 70 countries, our reputation is underpinned by 20+ distinguished accreditations. Our portfolio boasts 900+ Marketing Authorizations, reinforcing our expertise & dedication to bringing the best to the healthcare community.

Read more Show less
Certifications
  • CE
    CE
  • FDA
    FDA
  • GMP
    GMP
  • ISO
    ISO
  • Other
More certifications Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • DE
  • 2019
    On CPHI since
  • 5
    Certificates
  • 1000 - 4999
    Employees
Company types
CMO/CDMO
Contract Research Organisation (CRO)
Generics/Biosimilars Manufacturer
Manufacturer/Innovator
Pharmaceutical company
Primary activities
Clinical Research
Contract Manufacturer
Contract Research Organisation
Custom Manufacturing/Custom Synthesis
Pharmaceutical Company (generic finished products)
Pharmaceutical Company (innovator finished products)
Regulatory Affairs
View company profile
Contact info
Show contact info Hide contact info
Meet us at

CPHI Milan 2024

Fiera Milano, Italy
08 Oct 2024 - 10 Oct 2024
View Exhibitor Profile

Products from Venus Pharma GmbH (5)

  • ANTIBIOTIC INJECTABLES (FOR CRITICAL CARE)

    Product ANTIBIOTIC INJECTABLES (FOR CRITICAL CARE)

    CEFEPIME FOR INJECTION | CEFTRIAXONE | CEFTAZIDIME FOR INJECTION | CEFOPERAZONE + SULBACTAM FOR INJECTION | CEFUROXIME FOR INJECTION | CEFOTAXIME FOR INJECTION | CEFTAZIDIME AVIBACTAM FOR INJECTION | CEFTRIAXONE SULBACTAM FOR INJECTION | ELORES: CEFTRIAXONE, SULBACTAM & EDTA FOR INJECTION | AZTREONAM F...
  • ONCOLOGY LIQUID INJECTABLES

    Product ONCOLOGY LIQUID INJECTABLES

    CARBOPLATIN | CISPLATIN | CYTARABINE LIQUID | DOCETAXEL WITH SOLVENT | DOCETAXEL (CTD) SINGLE VIAL | DOXORUBICIN | EPIRUBICINE | ETOPOSIDE  | IRINOTECAN | LEUCOVORIN CALCIUM | METHOTREXATE | OXALIPLATIN | PLERIXAFOR | PACLITAXEL  | VINCRISTINE | 5-FLOUROURACIL | FULVESTRANT
  • ONCOLOGY LYOPHILIZED INJECTABLES

    Product ONCOLOGY LYOPHILIZED INJECTABLES

    AZACITIDINE | BENDAMUSTINE  | BLEOMYCIN | BORTEZOMIB | CYTARABINE  | DACARBAZINE | EPIRUBICIN  | GEMCITABINE | PEMETREXED | TOPOTECAN | ZOLENDRONIC ACID
  • PREFILLED SYRINGE (ENOXOPARIN) BIOSIMILAR

    Product PREFILLED SYRINGE (ENOXOPARIN) BIOSIMILAR

    ENOXAPARIN PFS 100MG/ML

  • OTHER INJECTABLES

    Product OTHER INJECTABLES

    REMDESIVIR FOR INJECTION | ACECLOFENAC | CISATRACURIUM BESYLATE | CITICOLINE | DEXMETOMIDINE | L-ORNITHINE L-ASPARTATE | MIDAZOLAM INJ | N-ACETYLCYSTEINE | SUGAMMADEX| PARACETAMOL

Venus Pharma GmbH Resources (2)

  • Venus Remedies Limited has secured vital marketing authorizations for essential medications in three countries.

    News Venus Remedies Limited has secured vital marketing authorizations for essential medications in three countries.

    Venus Remedies Limited has secured vital marketing authorizations for essential medications in three countries. Zoledronic Acid and Paclitaxel will now reach patients in the Philippines, while Bleomycin will become accessible in Saudi Arabia. Azerbaijan also welcomes Enoxaparin sodium injection, marking a significant step towards dismantling healthcare barriers and ensuring patients have access to life-saving solutions. This achievement fuels our mission to improve global health, one approval at a time.
    4 Mar 2024
  • Venus Remedies Limited Receives Market Authorizations in Saudi Arabia and the Philippines

    Brochure Venus Remedies Limited Receives Market Authorizations in Saudi Arabia and the Philippines

    Venus Remedies Limited recently obtained regulatory approval for the marketing of three essential drugs in Saudi Arabia and the Philippines.

    In the dynamic region of Asia, Venus Remedies has received approval for Paclitaxel 100mg/16.7ml and Zoledronic Acid 4mg in the Philippines. These medications are crucial components in the treatment of various medical conditions. Paclitaxel, an anti-cancer drug, is widely used in the management of breast, ovarian, and lung cancers. Zoledronic Acid, a bisphosphonate, is instrumental in the prevention and treatment of bone-related complications in cancer patients, such as fractures and bone pain.